PD-1 and PD-L1 Blockade plus Chemotherapy in Endometrial Cancer. Reply

Mansoor R Mirza*, Mathew A Powell

*Corresponding author for this work
Original languageEnglish
JournalThe New England journal of medicine
Volume389
Issue number9
Pages (from-to)867
ISSN0028-4793
DOIs
Publication statusPublished - 31 Aug 2023

Keywords

  • Humans
  • Female
  • Programmed Cell Death 1 Receptor
  • B7-H1 Antigen
  • Endometrial Neoplasms/drug therapy
  • Antibodies, Monoclonal, Humanized/therapeutic use

Cite this